Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer.
暂无分享,去创建一个
G. Scagliotti | J. von Pawel | J. Vansteenkiste | R. Martins | P. Parikh | C. Manegold | C. Visseren-Grul | L. Simms | K. Sugarman | K. Syrigos